Amphastar Pharmaceuticals, Inc. Quarterly Selling and Marketing Expense in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2013 to Q2 2024.
  • Amphastar Pharmaceuticals, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $9.01M, a 34.1% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $33.4M, a 38.7% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2023 was $28.9M, a 34% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2022 was $21.5M, a 23.1% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2021 was $17.5M, a 18.3% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $33.4M $9.01M +$2.29M +34.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $31.1M $9.37M +$2.26M +31.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $28.9M $8.62M +$3.15M +57.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $25.7M $6.41M +$1.62M +33.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $24.1M $6.72M +$962K +16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $23.1M $7.11M +$1.59M +28.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $21.5M $5.47M +$1.4M +34.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $20.1M $4.78M +$39K +0.82% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $20.1M $5.76M +$1.63M +39.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $18.5M $5.52M +$982K +21.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $17.5M $4.08M +$288K +7.61% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $17.2M $4.75M +$1.07M +29.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $16.1M $4.13M +$103K +2.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $16M $4.54M +$1.24M +37.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $14.8M $3.79M +$311K +8.95% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $14.5M $3.67M +$452K +14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $14M $4.03M +$1.03M +34.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $13M $3.29M +$153K +4.87% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $12.8M $3.48M +$880K +33.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $12M $3.22M +$1.26M +64.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $10.7M $2.99M +$1.12M +59.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $9.58M $3.14M +$1.42M +82.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $8.16M $2.6M +$967K +59.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $7.19M $1.96M +$207K +11.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $6.98M $1.88M +$280K +17.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $6.7M $1.72M +$242K +16.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $6.46M $1.63M +$138K +9.26% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $6.32M $1.76M +$465K +36% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $5.86M $1.6M +$264K +19.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $5.59M $1.48M +$127K +9.39% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $5.47M $1.49M +$184K +14.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $5.28M $1.29M +$120K +10.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $5.16M $1.33M -$138K -9.39% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $5.3M $1.35M -$170K -11.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $5.47M $1.31M -$192K -12.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $5.66M $1.17M -$283K -19.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $5.95M $1.47M +$118K +8.73% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $5.83M $1.52M +$263K +20.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $5.56M $1.5M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $1.45M -$8K -0.55% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $1.35M +$149K +12.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $1.26M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $1.46M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $1.2M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.